Literature DB >> 26617745

MicroRNA 181b promotes vascular smooth muscle cells proliferation through activation of PI3K and MAPK pathways.

Tie-Jun Li1, Yan-Li Chen1, Chao-Jun Gua1, Sheng-Jiang Xue2, Shu-Mei Ma1, Xiao-Dong Li1.   

Abstract

Vascular smooth muscle cells (VSMCs) hyperplasia is a common feature of pathologic cardiovascular event such as restenosis and atherosclerosis. The role and mechanisms of microRNAs (miRs) in VSMCs proliferation are poorly understood. Here, we report that miR-181b promotes VSMCs proliferation and migration. In an animal model, miR-181b was significantly increased in the rat carotid artery after balloon catheter injury. Delivery of miR-181b inhibitor to injured artery exhibited a marked inhibition of neointimal hyperplasia. Transfection of miR-181b with "mimics" to A10 cells accelerated cell proliferation, which was accompanied by an increase of cell migration. The induction of A10 cells proliferation by miR-181b appeared to be involved in activation of S and G2/M checkpoint, concomitant with decreases in cell-cycle inhibitors p21 and p27, and increases in cell-cycle activators CDK4 and cyclinD1. In contract, miR-181b inhibition attenuated A10 cells proliferation, inhibited cell migration and arrested cell cycle transition. Moreover, forced miR-181b expression elevated the phosphorylation levels of Akt and Erk1/2, whereas inhibition of miR-181b produced the opposite effects. Additionally, inhibition of PI3K and MAPK signaling pathways with specific inhibitors, but not inhibition of JNK pathway, significantly abolished the effects of miR-181b in promoting cell proliferation. These findings demonstrate that miR-181b enhances the proliferation and migration of VSMCs through activation of PI3K and MAPK pathways.

Entities:  

Keywords:  Neointimal formation; miRNA-181b; proliferation; vascular smooth muscle cells

Mesh:

Substances:

Year:  2015        PMID: 26617745      PMCID: PMC4637560     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  22 in total

Review 1.  The functions of animal microRNAs.

Authors:  Victor Ambros
Journal:  Nature       Date:  2004-09-16       Impact factor: 49.962

2.  2-Methoxyestradiol, an estradiol metabolite, inhibits neointima formation and smooth muscle cell growth via double blockade of the cell cycle.

Authors:  Federica Barchiesi; Edwin K Jackson; Juergen Fingerle; Delbert G Gillespie; Bernhard Odermatt; Raghvendra K Dubey
Journal:  Circ Res       Date:  2006-06-22       Impact factor: 17.367

Review 3.  Principles of CDK regulation.

Authors:  D O Morgan
Journal:  Nature       Date:  1995-03-09       Impact factor: 49.962

4.  Tanshinone IIA Prevents Rat Basilar Artery Smooth Muscle Cells Proliferation by Inactivation of PDK1 During the Development of Hypertension.

Authors:  Zhi-Liang Yu; Jie-Ning Wang; Xiao-Hua Wu; Hui-Jun Xie; Ying Han; Yang-Tai Guan; Yong Qin; Jian-Ming Jiang
Journal:  J Cardiovasc Pharmacol Ther       Date:  2015-03-02       Impact factor: 2.457

5.  Multiple growth factors are released from mechanically injured vascular smooth muscle cells.

Authors:  S T Crowley; C J Ray; D Nawaz; R A Majack; L D Horwitz
Journal:  Am J Physiol       Date:  1995-11

6.  miR-181b promotes cell proliferation and reduces apoptosis by repressing the expression of adenylyl cyclase 9 (AC9) in cervical cancer cells.

Authors:  Lei Yang; Yan-Li Wang; Shang Liu; Pei-Pei Zhang; Zheng Chen; Min Liu; Hua Tang
Journal:  FEBS Lett       Date:  2013-11-20       Impact factor: 4.124

Review 7.  Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia.

Authors:  M W Liu; G S Roubin; S B King
Journal:  Circulation       Date:  1989-06       Impact factor: 29.690

8.  MiR-181b-5p downregulates NOVA1 to suppress proliferation, migration and invasion and promote apoptosis in astrocytoma.

Authors:  Feng Zhi; Qiang Wang; Danni Deng; Naiyuan Shao; Rong Wang; Lian Xue; Suinuan Wang; Xiwei Xia; Yilin Yang
Journal:  PLoS One       Date:  2014-10-09       Impact factor: 3.240

9.  Lentivirus-mediated RNAi knockdown of the gap junction protein, Cx43, attenuates the development of vascular restenosis following balloon injury.

Authors:  Xiao-Jian Han; Min Chen; Tao Hong; Ling-Yu Zhu; Dan He; Jiu-Geng Feng; Li-Ping Jiang
Journal:  Int J Mol Med       Date:  2015-01-23       Impact factor: 4.101

10.  MicroRNA-365 inhibits vascular smooth muscle cell proliferation through targeting cyclin D1.

Authors:  Peng Zhang; Cuiying Zheng; Hui Ye; Yan Teng; Bin Zheng; Xiao Yang; Jishuai Zhang
Journal:  Int J Med Sci       Date:  2014-05-21       Impact factor: 3.738

View more
  14 in total

1.  The novel miR-9501 inhibits cell proliferation, migration and activates apoptosis in non-small cell lung cancer.

Authors:  Yongyong Xi; Liang Wang; Chengcao Sun; Cuili Yang; Feng Zhang; Dejia Li
Journal:  Med Oncol       Date:  2016-10-12       Impact factor: 3.064

2.  Systemic Treatment of Metastatic/Recurrent Uterine Leiomyosarcoma: A Changing Paradigm.

Authors:  Rebecca C Arend; Michael D Toboni; Allison M Montgomery; Robert A Burger; Alexander B Olawaiye; Bradley J Monk; Thomas J Herzog
Journal:  Oncologist       Date:  2018-08-23

3.  Exosomal microRNA-21-5p Mediates Mesenchymal Stem Cell Paracrine Effects on Human Cardiac Tissue Contractility.

Authors:  Joshua Mayourian; Delaine K Ceholski; Przemek A Gorski; Prabhu Mathiyalagan; Jack F Murphy; Sophia I Salazar; Francesca Stillitano; Joshua M Hare; Susmita Sahoo; Roger J Hajjar; Kevin D Costa
Journal:  Circ Res       Date:  2018-02-15       Impact factor: 17.367

4.  MiR-665 regulates VSMCs proliferation via targeting FGF9 and MEF2D and modulating activities of Wnt/β-catenin signaling.

Authors:  Kai Li; Jin Pan; Jianjun Wang; Fengrui Liu; Li Wang
Journal:  Am J Transl Res       Date:  2017-10-15       Impact factor: 4.060

5.  MiR-33 regulation of stretch-induced intimal hyperplasia in vein grafts.

Authors:  Xinbo Zhang; Carlos Fernández-Hernando
Journal:  Cardiovasc Res       Date:  2017-04-01       Impact factor: 10.787

6.  microRNA-612 is downregulated by platelet-derived growth factor-BB treatment and has inhibitory effects on vascular smooth muscle cell proliferation and migration via directly targeting AKT2.

Authors:  Chen Chen; Yan Yan; Xiaodan Liu
Journal:  Exp Ther Med       Date:  2017-11-01       Impact factor: 2.447

7.  Decreased production of class-switched antibodies in neonatal B cells is associated with increased expression of miR-181b.

Authors:  Stephanie Glaesener; Christine Jaenke; Anika Habener; Robert Geffers; Petra Hagendorff; Katrin Witzlau; Esther Imelmann; Andreas Krueger; Almut Meyer-Bahlburg
Journal:  PLoS One       Date:  2018-02-01       Impact factor: 3.240

8.  MiR-137 inhibited cell proliferation and migration of vascular smooth muscle cells via targeting IGFBP-5 and modulating the mTOR/STAT3 signaling.

Authors:  Jin Pan; Kai Li; Wei Huang; Xiaoqing Zhang
Journal:  PLoS One       Date:  2017-10-10       Impact factor: 3.240

9.  Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas.

Authors: 
Journal:  Cell       Date:  2017-11-02       Impact factor: 41.582

10.  miR-34c inhibits PDGF-BB-induced HAVSMCs phenotypic transformation and proliferation via PDGFR-β/SIRT1 pathway.

Authors:  Wei-Feng Wan; Xin Zhang; Chang-Ren Huang; Li-Gang Chen; Xiao-Bo Yang; Kun-Yang Bao; Tang-Ming Peng
Journal:  Mol Biol Rep       Date:  2021-06-10       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.